Plain-English translation of NCT03145077 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This trial is testing whether a special type of MRI scan called dynamic contrast-enhanced MRI (DCE-MRI) can predict osteoradionecrosis โ a serious condition where the jaw bone becomes damaged and dies after radiation therapy for head and neck cancer. Researchers will follow patients over time with repeated MRI scans to see if this imaging can reliably warn doctors when bone damage is likely to occur, and whether it can help monitor how well treatments are working.
Jaw bone damage is a known but serious side effect of radiation therapy for head and neck cancer, and doctors currently have no reliable way to predict who will develop it before damage occurs. If this MRI scan can identify early warning signs, doctors could intervene sooner to prevent severe complications or plan better treatment strategies.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
Depending on which group you join, you will receive MRI scans at different time points. If you are newly diagnosed, you'll have scans before radiation starts, a few weeks after it begins, and then at 2, 6, 12, 24, and 36 months after treatment. If you've already had radiation, you'll have 2โ5 scans over several years. If you're being treated for jaw bone damage, you'll have scans before treatment and at 2 and 6 months afterward. Each MRI scan takes about 30โ60 minutes, and the study continues for up to 4 years depending on your group.
AI-generated summary from trial data ยท Jul 1, 2026 ยท Not medical advice
United States